Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Not Confirmed
Not Confirmed
05-06 June, 2025
Not Confirmed
Not Confirmed
05-06 June, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Europ. Pharma Outsourc...Europ. Pharma Outsourcing
Industry Trade Show
Not Confirmed
05-06 June, 2025
Industry Trade Show
Not Confirmed
05-06 June, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-roquette-announces-restructuring-post-iff-pharma-buyout-who-fda-advance-regulatory-frameworks
28 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorm-secures-key-manufacturing-partnership-with-minaris-for-upcoming-nurown-phase-3b-als-clinical-trials-302465726.html
15 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-announces-first-quarter-2025-financial-results-and-provides-corporate-update-302456908.html
07 May 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-to-announce-first-quarter-results-and-provide-a-corporate-update-on-may-15-2025-302448401.html
29 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorms-nurown-data-selected-as-breakthrough-science-for-presentation-at-isct-2025-meeting-302441062.html
10 Apr 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorm-cell-therapeutics-submits-ind-amendment-to-fda-paving-the-way-for-phase-3b-trial-of-nurown-in-als-302425558.html
30 Dec 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/brainstorm-issues-2024-letter-to-shareholders-302340138.html
ABOUT THIS PAGE